Computed Tomography (CT) Market: By Type (Low Slice CT Scanner (<64 slices), Medium Slice CT Scanner (64 slices), and High Slice CT Scanner (>64 slices)), by Application (Oncology, Cardiovascular, Musculoskeletal, Neurovascular, Spinal, Others), by End User (Hospitals, Diagnostic Centres), By Geography


Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Computed Tomography (CT) Market size was valued at USD 4,023.4 million in 2021, growing at a CAGR of 7.2% during the forecast period 2022 to 2028. CT scans are medical imaging examinations that use a motorised X-Ray source to provide comprehensive images of interior organs, bones, soft tissue, and blood arteries. CT scans create cross-sectional images that can be reformatted as needed, as well as 3D images that may be viewed on a computer screen or printed on film. Computed tomography (CT) is an analytic imaging test used to create detailed images of inward organs, bones, delicate tissue and veins. The cross-sectional pictures created amid a CT output can be reformatted in different planes, and can even produce three-dimensional pictures which can be seen on a computer screen, imprinted on film or exchanged through electronic media. CT scanning is frequently the best technique for distinguishing a wide range of malignancies since the pictures enable your specialist to affirm the nearness of a tumor and decide its size and area. CT is quick, easy, non-invasive and exact. The players in the computed tomography (CT) market are teaming up with creative arrangements suppliers to drive development. For example, in November 2017, the Sectra Corporation (Sectra), a global therapeutic imaging data innovation organization consented to a dissemination arrangement with El Seif Development Company (El Seif). In January 2017, Bruker microCT (Bruker), backup of Bruker Corporation and iTomography Corporation (iTomo) went into a multiyear permit assention for the product innovation created by iTomo. This furnished Bruker with non-selective rights to the product created through iTomo’s picture recreation calculation.

Computed Tomography Ct Market Summary

Study Period


Base Year




Largest Market

North America

Fastest Growing Market

Computed Tomography (CT) Market Dynamics

The Computed Tomography (CT) Market is driven by the increased prevalence of diseases, awareness on early diagnosis of diseases and diagnostic technology advancements such as 3D technologies. In addition, advancements in diagnostic equipment led to multiple applications of diagnostic devices, better monitoring, easy to use and quick diagnosis of diseases is further driving Computed Tomography (CT) market. However, high cost for diagnostic imaging, risk of cancer due to radiation, stringent regulatory procedures are hindering Computed Tomography (CT) market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018-2022), and forecast (2023-2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Computed Tomography Ct Market Segmentation

By Type
  • Low Slice CT Scanner (<64 Slices)
  • Medium Slice CT Scanner (64 Slices)
  • High Slice CT Scanner (>64 Slices)
By Application
  • Cardiovascular
  • Oncology
  • Neurovascular
  • Spinal Application
  • Others
By End User
  • Hospitals
  • Diagnostic centres
  • Home Care
  • Ambulatory surgical centres

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

  • AxoGen Inc. (U.S.)
  • Baxter International (U.S.)
  • Medtronic (US)
  • Cyberonics Inc. (U.S.)
  • Integra Lifesciences Corporation (U.S.)
  • Boston Scientific (US)
  • Abbott Laboratories (US)
  • LivaNova (UK)
  • Baxter (US)
  • AxoGen (US)
  • Stryker (US)